|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1
Department of Exercise and Sport Science, Manchester Metropolitan University, Hassall Road, Alsager, ST7 2HL, UK
2
Department of Anaesthesia, Wythenshawe Hospital, Manchester, M23 9LT, UK
We hypothesized that the effective inhibition of nitric oxide synthase (NOS), achieved via systemic infusion of NG-nitro-L-arginine methyl ester (L-NAME), would reduce the gas exchange threshold (GET) and the maximal oxygen uptake (
O2max) during incremental cycle exercise in man if NO is important in the regulation of muscle vasodilatation. Seven healthy males, aged 1834 years, volunteered to participate in this ethically approved study. On two occasions, the subjects completed an incremental exercise test to exhaustion on an electrically braked cycle ergometer following the infusion of either L-NAME (4 mg kg1 in 50 ml saline) or placebo (50 ml saline, CON). At rest, the infusion of L-NAME resulted in a significant increase in mean arterial pressure (MAP; CON vs. L-NAME, 89 ± 8 vs. 103 ± 11 mmHg (mean ± S.D.; P < 0.05)) and a significant reduction in heart rate (HR; CON vs. L-NAME, 60 ± 12 vs. 51 ± 8 beats min1; P < 0.01). At submaximal work rates, there was no significant difference in
O2 between the conditions and no difference in the GET (CON vs. L-NAME, 1.94 ± 0.47 vs. 2.01 ± 0.41 l min1). However, at higher work rates, differences in
O2 between the conditions became more pronounced such that
O2max was significantly lower with L-NAME (CON vs. L-NAME, 4.02 ± 0.41 vs. 3.80 ± 0.34 l min1; P < 0.05). The reduction in
O2max was associated with a reduction in HRmax (CON vs. L-NAME, 186 ± 10 vs. 178 ± 7 beats min1; P < 0.01). These results demonstrate that NOS inhibition with L-NAME has no effect on GET but reduces
O2max during large muscle group exercise in man, presumably by direct or indirect effects on cardiac output and muscle blood flow.
(Received 1 April 2004;
accepted after revision 28 July 2004;
first published online 29 July 2004)
Corresponding author A. M. Jones: Department of Exercise and Sport Science, Manchester Metropolitan University, Hassall Road, Alsager, ST7 2HL, UK. Email: a.m.jones{at}mmu.ac.uk
This article has been cited by other articles:
![]() |
L. Schaffer, J. Vogel, C. Breymann, M. Gassmann, and H. H. Marti Preserved placental oxygenation and development during severe systemic hypoxia Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2006; 290(3): R844 - R851. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. P Wilkerson, J. Rittweger, N. J. A Berger, P. F Naish, and A. M Jones Influence of recombinant human erythropoietin treatment on pulmonary O2 uptake kinetics during exercise in humans J. Physiol., October 15, 2005; 568(2): 639 - 652. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. P Wilkerson, I. T Campbell, and A. M Jones Influence of nitric oxide synthase inhibition on pulmonary O2 uptake kinetics during supra-maximal exercise in humans J. Physiol., December 1, 2004; 561(2): 623 - 635. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |